|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.57 CNY | -3.53% |
|
+5.21% | +5.39% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 4.85% | 5.35% | 14.25x | 2.67x | 0.59x | 4.69x | 7.74x | 3.12B | |
| -.--% | -.--% | 17.52x | 1.54x | 0.73x | 11.43x | 12.27x | 15.14B | |
| 0.99% | 1.23% | 22.93x | 2.54x | 0.91x | 15.97x | 16.23x | 6.93B | |
| 2.25% | 2.55% | 16.6x | 1.75x | 0.75x | 7.78x | 9.78x | 6.13B | |
| 3.25% | 3.59% | 13.17x | 1.98x | 0.84x | 6.06x | 7.93x | 3.73B | |
| 4.06% | 4.45% | 15.8x | 7.15x | 0.96x | 7.22x | 10.04x | 3.25B | |
| 5.53% | 6.29% | 13.95x | 4.23x | 1.19x | 7.23x | 13.88x | 3.13B | |
| 1.79% | 2.17% | 22.93x | 4.01x | 0.66x | 8.44x | 13.81x | 1.67B | |
| 0.01% | -.--% | -89.13x | 2.93x | 0.47x | 17.39x | 105.15x | 1.55B | |
| 4.19% | 4.72% | 12.12x | 0.86x | 0.29x | 2.79x | 5.75x | 959M | |
| 5.73% | 5.54% | 14.58x | 2.41x | 0.85x | 6.94x | 14.92x | 923M | |
| 1.26% | 1.82% | 27.99x | 7.72x | 1.02x | 13.94x | 21.27x | 858M | |
| 0.36% | 0.37% | 14.46x | 1.95x | 0.69x | 8.47x | 13.67x | 708M | |
| Average | 2.64% | 2.93% | 9.01x | 3.21x | 0.76x | 9.10x | 19.42x | 3.7B | |
| Weighted average by Cap. | 1.91% | 2.15% | 14.01x | 2.62x | 0.79x | 10.04x | 15.00x |
Select your edition
All financial news and data tailored to specific country editions
